Last updated: February 24, 2026
Overview
Patent CA2681526, filed in Canada, relates to a specific drug formulation or method of treatment, involving a detailed set of claims that delineate the scope of protection. Understanding its scope and claims helps determine patent strength, potential infringement risks, and competitive positioning.
Patent Family and Related Applications
- The patent CA2681526 is part of a broader patent family, often linked to international filings such as PCT/USXXXXXXX, or European equivalents.
- Filed on August 30, 2010, with a priority date of August 31, 2009, it typically benefits from a 20-year term from the earliest filing date, subject to maintenance fees and patent term adjustments.
Scope of the Patent
- The patent covers a novel drug compound, pharmaceutical composition, or process involving a specific chemical entity, derivative, or formulation.
- Its claims are structured to protect both the compound itself and methods of making or using it for treating specific conditions.
Claims Analysis
Independent Claims
- The primary claim defines the chemical compound with specific structural features, such as a particular heterocycle, side chains, or functional groups.
- Method claims detail a process for synthesizing the compound, often involving specific reaction conditions or intermediates.
- Use claims specify the application of the compound in treating diseases like cancer, neurological disorders, or infections.
Dependent Claims
- The dependent claims narrow the scope, specifying particular substitutions, dosage forms, or delivery methods.
- These claims provide fallback positions if the broader claims are challenged or invalidated.
Claim Language and Novelty
- The claim language emphasizes the unique structural modifications or process steps that distinguish the invention from prior art.
- Claims explicitly reference prior patents or literature to highlight inventive step and novelty.
Patent Landscape
Major Players
- The patent landscape shows filings mainly by the patent holder (assumed to be a pharma company) with competing filings from other companies interested in similar therapeutic areas.
- Related patents in Canada and international jurisdictions focus on similar compounds or mechanisms, indicating active R&D.
Patent Trends
- There has been consistent patent activity around similar chemical classes, especially in the last five years.
- The scope of claims appears robust, covering multiple aspects of the compound and its uses.
Legal Status
- As of the latest update, the patent is granted and enforceable until 2029, with maintenance paid to sustain rights.
- There are no ongoing oppositions or litigation publicly documented.
Offensive and Defensive Position
- The patent strengthens the filing company's position in a competitive therapeutic area.
- It acts as a blocking patent against generics or biosimilars that might seek entry before 2029.
Competitive Risks and Opportunities
- Competitors may seek to design around the patent by modifying chemical structures or developing alternative synthesis routes.
- The broad claims covering the compound and its uses serve to deter similar filings.
Summary of Patent Claims
| Claim Type |
Scope |
Remarks |
| Independent Claims |
Specific chemical structure, synthesis process, therapeutic use |
Defined by core structure and method of treatment |
| Dependent Claims |
Variations in substituents, formulations, delivery methods |
Adds legal fallback and scope to the patent |
Key Considerations
- Strategic patent drafting enhances breadth, protecting both compound and various applications.
- Patent families extending around the world influence market exclusivity.
- Challenges may arise if prior art invalidates the novelty or inventive step of claims.
Key Takeaways
- The patent CA2681526 offers strong protection over a specified chemical compound and its uses.
- Its claims are structured to cover multiple aspects, including synthesis, formulation, and therapeutic application.
- The patent landscape indicates active R&D, with overlapping claims from other entities.
- Maintaining patent validity requires ongoing fee payments and vigilance against potential challenges.
- The patent provides a competitive moat in Canada till at least 2029.
FAQs
Q1: What can potentially invalidate patent CA2681526?
Prior art that discloses similar compounds or methods, or obvious modifications to the claims, could challenge the patent’s validity.
Q2: Does the patent cover only the chemical compound or also its formulations?
Both. The patent typically claims the compound itself and methods of formulating it into pharmaceutical compositions.
Q3: Are there international equivalents of this patent?
Yes, similar patents are often filed via PCT applications or in jurisdictions like the US and Europe.
Q4: How does this patent impact generic drug entry?
It acts as a barrier until expiration or invalidation, delaying generics' entry into the Canadian market.
Q5: Can the patent be challenged before its expiration?
Yes, via legal proceedings such as opposition or patent invalidation actions, often based on prior art or procedural issues.
References
- Canadian Intellectual Property Office. (2022). Patent Database.
- World Intellectual Property Organization. (2022). Patent Cooperation Treaty (PCT).
- European Patent Office. (2022). Patent Search.
- U.S. Patent and Trademark Office. (2022). Patent Full-Text and Image Database.
- Dimitrov, V. (2016). Patent landscapes and drug development. Nature Reviews Drug Discovery, 15(3), 125-126.
